Navigation Links
Mark C. Mirken Named New CEO and Chairman of the Board of Millennium Biotechnologies, Inc.
Date:8/6/2008

BASKING RIDGE, N.J., Aug. 6 /PRNewswire-FirstCall/ -- Millennium Biotechnologies, Inc., a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. (OTC Bulletin Board: MBTG) today named Mark C. Mirken its new Chief Executive Officer and Chairman of its Board of Directors.

Mirken has been President and Chief Operating Officer of Millennium since he joined the Company in September of 2007. Mirken will replace Jerry Swon who has been Chief Executive Officer and Board Chairman since 2001. Mr. Swon will be retiring from these positions to pursue other business interests.

"In the short time that Mark has been with Millennium he has demonstrated a complete set of business skills and decisive leadership in designing, developing, marketing and selling a Ready-to-Drink product that is gaining significant market acceptance. Mark has created a new and dynamic product and a growing domestic and international customer base. The Agreements he has developed with Ferring Pharmaceuticals of Canada, a division of the international billion dollar drug conglomerate, is the beginning of significant international opportunities. Our three year manufacturing contract with General Electric subsidiary Farmland Dairies will anchor the domestic growth of our Ready-to-Drink product in the immuno-compromised and Long Term Care and Sports Channels. At this point in the Company's history we are extremely fortunate to have a person with Mark's business development capabilities and strategic vision to continue to build and develop the Company's products and line extensions in both its clinical and sports businesses," said Mr. Swon.

"I am extremely excited about the ability to move Millennium in the commercialization of its product lines and leverage and enhance its intellectual assets. I feel strongly that we must shed our past and move quickly to establish beachheads in the lucrative channels we have initiated while concurrently developing similar opportunities i
'/>"/>

SOURCE Millennium Biotechnologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
2. Dr. George Poste Named Non-Executive Vice Chairman of CDX Holdings, Parent of Caris Diagnostics and Caris Molecular Diagnostics
3. MicroMass President Jay Bigelow Named to PharmaVOICE List of 100 Most Inspiring and Influential Leaders in the Life Sciences
4. Raj Khankari Named Bioenergy, Inc., CEO
5. Samarion CEO Mark Rodgers Named CAST Commissioner
6. North Carolina Marketing Firm MicroMass Named One of Top 60 Healthcare Agencies in U.S.
7. Quintiles Named to Computerworld Magazines 100 Best Places to Work in Information Technology List
8. WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises
9. Agensys Founder, President, & CEO Dr. Donald Rice Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Winner for the Greater Los Angeles Area
10. Tolerx Named as One of the Fierce 15 Biotech Companies of 2008
11. Brian Levy, OD, MSc, Named Chief Operating Officer of Danube Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... 18, 2013 The Regulatory Affairs ... two new offices in Asia—one in Singapore and one ... as RAPS’ Pan-Asia office , serving the Asia ... focused on audiences within China. , The announcement comes ... with five Singapore government agencies to develop and implement ...
(Date:6/18/2013)... 18, 2013 RegeneCure announced ...  proprietary AMCA Guided Bone Regeneration (GBR) Dental Membrane as a ... A common problem encountered when patients have a tooth replaced ... volume to house the implant. Consequently there is often a ... the natural bone regenerates. The bone substitute material, in turn, ...
(Date:6/18/2013)... 18, 2013 The "Bioinformatics Market By Sector ... Management Tools & Data Analysis Services) & Application (Genomics, Proteomics ... Major Market Drivers, Restraints, and Opportunities in North ... Asia-Pacific and Rest of World. Browse ... 22 Figures 364 Pages ...
(Date:6/18/2013)... , June 18, 2013 ... has announced the addition of the ... Microspheres, & Nanoparticles], Devices [Disposables & Reusable, ... Auto Injectors] & Therapeutics [Diabetes & Oncology] ... to their offering.      (Logo: ...
Breaking Biology Technology:RAPS Opens Offices in Singapore and China 2RAPS Opens Offices in Singapore and China 3RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 2RegeneCure Starts Clinical Study Using Polymeric Bone Stimulating Membrane for Dental Implants 3Bioinformatics Market Worth $7.5 Billion by 2017 2Bioinformatics Market Worth $7.5 Billion by 2017 3Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
... 5 DURECT Corporation,(Nasdaq: DRRX ) announced today ... 31, 2007. Total revenues were $6.6 million for the,three ... for the same,period in 2006. Net loss for the ... to a net loss of $9.8 million for the ...
... ST. LOUIS, Feb. 5 Monsanto Company,s ... global commercial,business, and Carl Casale, executive vice ... in separate presentations at two,conferences later this ... an update on the company,s,business performance and ...
... BEIJING and CLAREMONT, Calif., Feb. 5 /Xinhua-PRNewswire-FirstCall/ ... Board: KWBT) reports,on a meeting between Kiwa ... and Dr.,Xiao-Dong Huang from the Department of ... the possibility of collaboration in research and,development ...
Cached Biology Technology:DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 2DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 3DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 4DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 5DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 6DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 7DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 8DURECT Corporation Announces Fourth Quarter and Year End 2007 Financial Results 9Kiwa Bio-Tech Products Group Discusses Cooperative Research With the University of Waterloo, Canada 2Kiwa Bio-Tech Products Group Discusses Cooperative Research With the University of Waterloo, Canada 3
(Date:6/18/2013)... Researchers from the United Kingdom, the Energy Department,s ... of Kentucky have recently published a paper describing ... borer Limnoria quadripunctata , commonly known as ... because they exhibit a relatively unique ability to ... microbes to break down the biomass they eat. ...
(Date:6/18/2013)... Research Council, Laboratory of Molecular Biology, has been ... Young Investigator Award. Torrent is being recognized for ... algorithm to predict antimicrobial regions in proteins. Luis ... now applying this algorithm to interrogate full genomes ... with very appealing results." , Torrent obtained ...
(Date:6/18/2013)... June 18, 2013 The herbal extract of a ... found to increase the lifespan of fruit fly populations ... Irvine researchers. , But it,s how Rhodiola ... this that grabbed the attention of study leaders Mahtab ... works in a manner completely unrelated to dietary ...
Breaking Biology News(10 mins):Novel enzyme from tiny gribble could prove a boon for biofuels research 2The American Society for Microbiology honors Marc Torrent 2Herbal extract boosts fruit fly lifespan by nearly 25 percent, UCI study finds 2
... eco-friendly fuel ethanol is usually made from grain, but the ... renewable materials that will be cost-effective alternatives, such as paper ... recently helped DOE do just that by analyzing the DNA ... structural component of plants that is also found in forestry ...
... Human embryonic stem cells (hESCs) hold great promise for ... mechanisms. Such cells can be grown in a manner ... and even without the need for immunosuppression. These were ... by an international collaboration led by Evan Y. Snyder, ...
... report citing the detrimental loss of sea ice ... many in the scientific community have been saying for years. ... Antonio's Department of Earth and Environmental Science are turning their ... warming is having similar effects in the frigid Antarctic region. ...
Cached Biology News:McBride shows DNA detective work with paper-eating bacteria that 'glide' 2McBride shows DNA detective work with paper-eating bacteria that 'glide' 3Stem cells act through multiple mechanisms to benefit mice with neurodegenerative disease 2Stem cells act through multiple mechanisms to benefit mice with neurodegenerative disease 3Stem cells act through multiple mechanisms to benefit mice with neurodegenerative disease 4Stem cells act through multiple mechanisms to benefit mice with neurodegenerative disease 5UTSA researchers examine effects of global warming on Antarctic 2
Rabbit polyclonal to P5 ( Abpromise for all tested applications). entrezGeneID: 10954 SwissProtID: Q14554...
Goat polyclonal to HA1 ( Abpromise for all tested applications). Antigen: Synthetic peptide: TLGSCRERQPEFV from the C terminus of human HA1. Entrez GeneID: 23526 Swiss Protein ID: O78181...
ATP-binding cassette sub-family D member 4 (Peroxisomal membrane protein 69) (PMP69) (Peroxisomal membrane protein 1-like) (PXMP1-L) (P70R). [Source:Uniprot/SWISSPROT;Acc:O14678] Antigen: Recombi...
Rabbit polyclonal to TAB1 ( Abpromise for all tested applications). entrezGeneID: 10454 SwissProtID: Q15750...
Biology Products: